Altaire Pharmaceuticals ActivEyes Altachlore Solution Recall

Why it was recalled

Lack of Assurance of Sterility

Product description

ActivEyes Altachlore Solution, 15 mL (1/2 FL OZ), Manufactured by Altaire Pharmaceuticals Inc., Aquebogue, NY 11931, NDC 59390-183-13

Lot numbers, UPCs & expiration codes

18008 1/20 8/13/2018 19050 2/22 3/18/2019 19105 4/22

Where it was sold

U.S.A. Nationwide

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0417-2020
Classification: Class II
Status: Completed
Recall initiated: Jul 2, 2019
FDA report date: Nov 27, 2019
Quantity: 22494 units
Recall type: Voluntary: Firm initiated
Recalling firm: Altaire Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0417-2020, exactly as published.

Show all FDA fields

City: Aquebogue
State: NY
Status: Completed
Country: United States
Event ID: 83265
Address: 311 W Ln
Address (line 2): PO Box 849
Code information: 18008 1/20 8/13/2018 19050 2/22 3/18/2019 19105 4/22
Postal code: 11931-0849
Report date: Nov 27, 2019
Product type: Drugs
Recall number: D-0417-2020
Classification: Class II
Recalling firm: Altaire Pharmaceuticals, Inc.
Product quantity: 22494 units
Reason for recall: Lack of Assurance of Sterility
Voluntary / mandated: Voluntary: Firm initiated
Product description: ActivEyes Altachlore Solution, 15 mL (1/2 FL OZ), Manufactured by Altaire Pharmaceuticals Inc., Aquebogue, NY 11931, NDC 59390-183-13
Distribution pattern: U.S.A. Nationwide
Recall initiation date: Jul 2, 2019
Initial firm notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date: Nov 15, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0417-2020, published Nov 27, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.